Adverse drug reactions, MedWatch reporting and medical student education

Pharmacoepidemiology and Drug Safety

Volumn 12, Issue 2, 2003, Pages 93-95

  Lewis, Lionel D ^a   Nierenberg, David W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CYCLOSPORIN; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; INFLIXIMAB; NEW DRUG; VACCINE;

DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HYPERSENSITIVITY REACTION; LUNG TUBERCULOSIS; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL STUDENT; MORBIDITY; PATIENT EDUCATION; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; EDUCATION, MEDICAL; INTERVENTION STUDIES; PHARMACEUTICAL PREPARATIONS; QUALITY ASSURANCE, HEALTH CARE; STUDENTS, MEDICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0037336529     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.801     Document Type: Editorial

References (18)

1. Beard K. Adverse reactions as a cause of hospital admissions in the aged. Drugs Ageing 1992; 2: 356-367.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
3. Schneeweiss S, Gottler M, Hasford J, et al. First results from an intensified monitoring system to estimate drug related hospital admissions. Br J Clin Pharmacol 2001; 52: 196-200.
4. Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm 1994; 47: 209-216.
5. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331-1336.
6. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
7. Committee on Quality of Health Care in America. Institute of Medicine. To Err is Human: Building a Safer Health System. National Academy Press: Washington DC, 2000.
8. Tyler LS, Nickman NA. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions. Am J Hosp Pharm 1992; 49: 845-850.
9. HHS News US Department of Health and Human Services, P93-121, June 3rd. 1993.
10. Bates DW. Drugs and adverse drug reactions: how worried should we be? JAMA 1998; 279: 1571-1573.
11. Piazza-Hepp TD, Kennedy DL. Reporting of adverse events to MedWatch. Am J Health Syst Pharm 1995; 52: 1436-1439.
12. Rosebraugh CJ, Tsong Y, Zhou F, et al. Improving the quality of adverse drug reaction reporting by 4th year medical students. Pharmacoepidemiol Drug Safe 2002 (This issue).
13. Rosebraugh CJ, Honig PK, Yasuda SU, Pezzullo JC, Woosley RL. Centers for education and research on therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United States. Clin Pharmacol Ther 2002; 71: 4-10.
14. Rosebraugh CJ, Honig PK, Yasuda SU, Pezzullo JC, Woosley RL. Formal education about medication errors in internal medicine clerkships. JAMA 2001; 286: 1019-1020.
15. Nierenberg DW, Stukel TA. The effects of a required fourth-year clinical pharmacology course on student attitudes and subsequent performance. Clin Pharmacol Ther 1986; 40: 488-493.
16. Nierenberg DW. A core curriculum for medical students in clinical pharmacology and therapeutics. The Council for Medical Student Education in Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther 1990; 48: 606-610.
17. Nierenberg DW. Commentary: clinical pharmacology instruction for all medical students. Clin Pharmacol Ther 1986; 40: 483-497.
18. Gray J, Lewis L, Nierenberg D. Clinical pharmacology education in primary care residency programs: Education Committee, American Society for Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther 1997; 62: 237-240.